Advertisement
U.S. markets open in 6 hours 32 minutes
S&P Futures
4,555.25 -0.75 (-0.02%) Dow Futures
36,111.00 -1.00 (-0.00%) Nasdaq Futures
15,815.50 +0.25 (+0.00%) Russell 2000 Futures
1,856.00 +1.20 (+0.06%) Crude Oil
69.91 +0.53 (+0.76%) Gold
2,047.20 -0.70 (-0.03%)
At close: 04:00PM EST
After hours:
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 107.14 |
| Open | 106.94 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 104.91 - 106.94 |
| 52 Week Range | 68.53 - 108.03 |
| Volume | |
| Avg. Volume | 2,045,958 |
| Market Cap | 26.094B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 173.56 |
| EPS (TTM) | 0.61 |
| Earnings Date | Jan 31, 2024 - Feb 05, 2024 |
| Forward Dividend & Yield | 2.00 (1.89%) |
| Ex-Dividend Date | Dec 29, 2023 |
| 1y Target Est | 108.75 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-13% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for CAH
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Cardinal Health, Inc.Analyst Report: Cardinal Health, Inc.Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its Pharmaceutical segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The Medical segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has about 44,000 employees. The shares are a component of the S&P 500.RatingFair ValueEconomic Moat10 days agoArgus Research
ZacksMcKesson (MCK) Announces Availability of FDA-Cleared Drug
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.
ZacksZacks.com featured highlights Cboe Global Markets, Cardinal Health, Assurant, Installed Building Products and FedEx
Cboe Global Markets, Cardinal Health, Assurant, Installed Building Products and FedEx have been highlighted in this Screen of The Week article.
MedTech DiveBD tells customers not to use Cardinal’s Monoject syringes with Alaris pumps
The FDA labeled BD's safety notice as a Class I event. The warning comes amid several actions from the agency on the safety of syringes.
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.